Impact of Covid-19 on delivery and receipt of prison healthcare in the UK and implications for health inequalities: a mixed methods study
- Funded by UK Research and Innovation (UKRI)
- Total publications:2 publications
Grant number: ES/W001810/1
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$282,074.09Funder
UK Research and Innovation (UKRI)Principal Investigator
Laura SheardResearch Location
United KingdomLead Research Institution
University of YorkResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Prisoners
Occupations of Interest
Unspecified
Abstract
We will produce robust evidence on the impact of Covid-19 on the delivery and receipt of prison healthcare in the UK, alongside an understanding of whether health inequalities have widened due to the pandemic. This will inform immediate clinical practice, commissioning and policy decisions at a regional and national level, in addition to providing planning UK wide recommendations for the recovery period. The application was written in response to the UKRI identified priority topic area "social impact upon vulnerable groups: the prison population". Our 12-month, mixed-methods study comprises three stages. First, we will undertake a scoping review of the literature to identify what is known already about Covid-19 and prison healthcare. Second, in a qualitative study we will interview 45 participants (people who have been in prison, prison healthcare staff and prison decision-makers) to explore their observations and beliefs about how and in what ways the pandemic has impacted on prison healthcare. Third, we will conduct an interrupted time series analysis to assess and compare change in recorded prison healthcare activity before, during and potentially after Covid-19. This analysis will utilise anonymised healthcare records from 13 prisons in England. The findings from all three stages will be formally integrated in a workshop. We will produce outputs for prison healthcare decision makers, clinicians, people currently or previously in prison and academics. Our well-connected team and existing prison healthcare research infrastructure means we can produce timely recommendations and directly influence national policy and practice as our findings emerge.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC